Page 2 - Adnay News Today

Codex DNA (NASDAQ:DNAY – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Insider and Institutional Ownership 87.6% of Codex DNA shares […]

Codex DNA (NASDAQ:DNAY – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its competitors? We will compare Codex DNA to similar businesses based on the strength of its profitability, analyst recommendations, valuation, risk, institutional ownership, dividends and earnings. Profitability This table compares […]

Codex DNA, Inc. (NASDAQ:DNAY – Get Rating) – Jefferies Financial Group upped their FY2022 earnings estimates for Codex DNA in a note issued to investors on Wednesday, May 11th. Jefferies Financial Group analyst B. Couillard now anticipates that the company will post earnings of ($2.10) per share for the year, up from their prior forecast […]

Codex DNA (NASDAQ:DNAY – Get Rating) issued its quarterly earnings data on Wednesday. The company reported ($0.45) EPS for the quarter, topping analysts’ consensus estimates of ($0.50) by $0.05, MarketWatch Earnings reports. Codex DNA had a negative return on equity of 43.84% and a negative net margin of 311.52%. Shares of NASDAQ:DNAY traded up $0.11 […]

Codex DNA (NASDAQ:DNAY – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Friday, Zacks.com reports. According to Zacks, “Codex DNA Inc. is a creator of the BioXp(TM) system, a fully automated benchtop instrument which enables numerous synthetic biology workflows. […]

Codex DNA (NASDAQ:DNAY – Get Rating) and Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Profitability This table compares Codex DNA and Rapid […]

Codex DNA, Inc. (NASDAQ:DNAY – Get Rating) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 1,980,000 shares, a growth of 37.5% from the March 15th total of 1,440,000 shares. Based on an average daily volume of 380,900 shares, the days-to-cover ratio is […]

Codex DNA (NASDAQ:DNAY – Get Rating) and Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation. Earnings & Valuation This table compares Codex DNA […]

Codex DNA (NASDAQ:DNAY – Get Rating) issued its quarterly earnings results on Tuesday. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.06), MarketWatch Earnings reports. Codex DNA updated its FY 2022 guidance to EPS. DNAY traded down $0.76 on Thursday, hitting $5.30. 1,160,977 shares of […]

В первом эфире шоу "Танцы со звездами" вслед за Александрой Зарицкий на паркет вышел певец Дмитрий Каднай, он же KADNAY